{"id":"https://openalex.org/W1532425160","doi":"https://doi.org/10.4049/jimmunol.188.supp.51.3","title":"Effective prevention and treatment of CD8 T cell-mediated graft-versus-host-like disease (GvHD) using a JAK inhibitor. (51.3)","display_name":"Effective prevention and treatment of CD8 T cell-mediated graft-versus-host-like disease (GvHD) using a JAK inhibitor. (51.3)","publication_year":2012,"publication_date":"2012-05-01","ids":{"openalex":"https://openalex.org/W1532425160","doi":"https://doi.org/10.4049/jimmunol.188.supp.51.3","mag":"1532425160"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.188.supp.51.3","doi":"https://doi.org/10.4049/jimmunol.188.supp.51.3","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.188.supp.51.3","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040895870","display_name":"Naoko Okiyama","orcid":"https://orcid.org/0000-0002-5398-0773","observed_orcids":["https://orcid.org/0000-0002-5398-0773"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naoko Okiyama","raw_affiliation_strings":["Dermatology Branch, NCI, NIH , Bethesda, MD","1Dermatology Branch, NCI, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Branch, NCI, NIH , Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"1Dermatology Branch, NCI, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021174004","display_name":"Yasuko Furumoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210087962","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasuko Furumoto","raw_affiliation_strings":["Translational Immunology Section, NIAMS, NIH , Bethesda, MD","2Translational Immunology Section, NIAMS, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Immunology Section, NIAMS, NIH , Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210087962"]},{"raw_affiliation_string":"2Translational Immunology Section, NIAMS, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031361479","display_name":"Vadim A. Villarroel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vadim Villarroel","raw_affiliation_strings":["Dermatology Branch, NCI, NIH , Bethesda, MD","1Dermatology Branch, NCI, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Branch, NCI, NIH , Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"1Dermatology Branch, NCI, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006332291","display_name":"Jan Gutermuth","orcid":"https://orcid.org/0000-0002-9252-6004","observed_orcids":["https://orcid.org/0000-0002-9252-6004"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan Gutermuth","raw_affiliation_strings":["Dermatology Branch, NCI, NIH , Bethesda, MD","1Dermatology Branch, NCI, NIH, Bethesda, MD","Specialities"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Branch, NCI, NIH , Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"1Dermatology Branch, NCI, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Specialities","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055619378","display_name":"Kamran Ghoreschi","orcid":"https://orcid.org/0000-0002-5526-7517","observed_orcids":["https://orcid.org/0000-0002-5526-7517"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210087962","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamran Ghoreschi","raw_affiliation_strings":["Translational Immunology Section, NIAMS, NIH , Bethesda, MD","2Translational Immunology Section, NIAMS, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Immunology Section, NIAMS, NIH , Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210087962"]},{"raw_affiliation_string":"2Translational Immunology Section, NIAMS, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079918193","display_name":"Massimo Gadina","orcid":"https://orcid.org/0000-0001-9084-6736","observed_orcids":["https://orcid.org/0000-0001-9084-6736"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210087962","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Massimo Gadina","raw_affiliation_strings":["Translational Immunology Section, NIAMS, NIH , Bethesda, MD","2Translational Immunology Section, NIAMS, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Immunology Section, NIAMS, NIH , Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210087962"]},{"raw_affiliation_string":"2Translational Immunology Section, NIAMS, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210087962"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111621701","display_name":"Stephen I. Katz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Katz","raw_affiliation_strings":["Dermatology Branch, NCI, NIH , Bethesda, MD","1Dermatology Branch, NCI, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Branch, NCI, NIH , Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"1Dermatology Branch, NCI, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"188","issue":"1_Supplement","first_page":"51.3","last_page":"51.3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.5692999958992004,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.5692999958992004,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.31049999594688416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12900","display_name":"Organ and Tissue Transplantation Research","score":0.02370000071823597,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":0.8690000176429749},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9190000295639038},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9679999947547913},{"id":"https://openalex.org/keywords/ot-i-t-cells","display_name":"OT-I T cells","score":0.8960000276565552},{"id":"https://openalex.org/keywords/ovalbumin","display_name":"ovalbumin","score":0.8309999704360962},{"id":"https://openalex.org/keywords/il-15-receptor","display_name":"IL-15 receptor","score":0.6470000147819519},{"id":"https://openalex.org/keywords/il-2-receptor","display_name":"interleukin-2 receptor","score":0.9819999933242798},{"id":"https://openalex.org/keywords/ifn-gamma-receptor","display_name":"IFN-gamma receptor","score":0.8970000147819519},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.7770000100135803},{"id":"https://openalex.org/keywords/cxcl9","display_name":"CXCL9","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":1.0},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.6620000004768372},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.7479298114776611},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6589090824127197},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5760573744773865},{"id":"https://openalex.org/C2776946954","wikidata":"https://www.wikidata.org/wiki/Q420291","display_name":"Ovalbumin","level":3,"score":0.49872827529907227},{"id":"https://openalex.org/C5858377","wikidata":"https://www.wikidata.org/wiki/Q986112","display_name":"CXCL10","level":4,"score":0.4791569113731384},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.46983784437179565},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4528464078903198},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.4490821063518524},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4481717646121979},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.43649935722351074},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.42555370926856995},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.3939347565174103},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3612281084060669},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3426581025123596},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3283691704273224},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3094087243080139},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1632750928401947},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.4049/jimmunol.188.supp.51.3","doi":"https://doi.org/10.4049/jimmunol.188.supp.51.3","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.188.supp.51.3","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:77285","doi":null,"is_oa":false,"landing_page_url":"https://biblio.vub.ac.be/vubir/effective-prevention-and-treatment-of-cd8-t-cellmediated-graftversushostlike-disease-gvhd-using-a-jak-inhibitor(8e16ac38-e5f4-4f24-9b30-328cf92fe542).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:77290","doi":null,"is_oa":false,"landing_page_url":"http://apps.webofknowledge.com.ezproxy.vub.ac.be:2048/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=X2aO@N1F8bA41nljPPj&page=1&doc=8]]>","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2039631176","https://openalex.org/W7096155026","https://openalex.org/W3106837305","https://openalex.org/W2486133439","https://openalex.org/W4307407875","https://openalex.org/W2408031701","https://openalex.org/W2095522674","https://openalex.org/W2135694095","https://openalex.org/W2031755145","https://openalex.org/W2170939701"],"abstract_inverted_index":{"Abstract":[0],"A":[1],"Janus":[2],"kinase":[3],"(JAK)":[4],"inhibitor,":[5],"tofacitinib":[6],"(tofa),":[7],"inhibits":[8],"JAK":[9,211],"1,":[10],"2":[11],"and":[12,24,69,91,96,100,137,153,181,215,221,227],"3":[13],"of":[14,54,127,134,140,164,187,202,210,218,225],"some":[15],"cytokine":[16],"receptor":[17],"pathways,":[18],"affects":[19,40],"CD4+":[20],"T":[21,42,57],"cell":[22,58,109,198],"respnses,":[23],"is":[25],"being":[26],"tested":[27],"in":[28,34,66,81,143,172,184,213,222,233],"more":[29],"than":[30],"20":[31],"clinical":[32,97,125],"trials":[33],"autoimmune":[35,234],"diseases.To":[36],"determine":[37],"if":[38],"tofa":[39,114,156,191,203,228],"CD8+":[41,50],"cells,":[43],"we":[44],"analyzed":[45],"its":[46,208],"effect":[47,201],"on":[48],"a":[49],"T-cell-dependent":[51],"murine":[52],"model":[53,83],"GvHD":[55,79],"(OT-I":[56],"transfer":[59],"into":[60],"Tg":[61],"mice":[62,86,148,189,193],"expressing":[63],"ovalbumin":[64],"(OVA)":[65],"their":[67],"skin":[68],"mucosae).":[70],"Tofa":[71,161],"at":[72,117],"50":[73,115,157],"mg/kg/day":[74],"(50)":[75],"p.o.":[76],"completely":[77,121],"prevented":[78],"development":[80],"our":[82],"vs.":[84,158,190],"vehicle-treated":[85,188],"with":[87,113,123,150,155],"final":[88],"weights:":[89],"-0.6%\u00b15.6":[90],"-15.4%\u00b14.1":[92],"(p<0.01;":[93,102],"2-way":[94],"ANOVA)":[95],"scores:":[98],"0":[99],"7.3\u00b10.52":[101],"U":[103],"test)":[104],"13":[105],"days":[106,195],"post":[107,196],"OT-I":[108,141,165,197,219],"transfer.":[110,199],"Mice":[111],"treated":[112,154],"starting":[116],"day":[118],"5":[119],"were":[120],"rescued,":[122],"no":[124],"signs":[126],"GVHD.":[128],"FACS":[129],"analysis":[130],"demonstrated":[131],"reduced":[132,138],"expression":[133],"OVA-specific":[135],"TCR":[136],"activation":[139],"cells":[142,152,166,220],"skin-draining":[144],"lymph":[145],"nodes":[146],"from":[147],"transferred":[149],"GFP/OT-I":[151],"vehicle":[159],"alone.":[160],"inhibited":[162],"proliferation":[163],"stimulated":[167],"by":[168,207],"SIINFEKL":[169],"(OVA":[170],"peptide)":[171],"vitro.":[173],"qRT-PCR":[174],"showed":[175],"increased":[176],"chemokine":[177],"mRNA":[178],"(CXCL9;":[179],"39-fold":[180],"CXCL10;":[182],"22-fold)":[183],"the":[185],"epidermis":[186],"50-treated":[192],"4":[194],"The":[200],"could":[204],"be":[205,231],"explained":[206],"inhibition":[209],"signaling":[212],"IL-2":[214],"IL-15":[216],"receptor-pathways":[217,224],"IFN-\u03b3":[223],"keratinocytes":[226],"may":[229],"thereby":[230],"effective":[232],"diseases.":[235]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}